Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
4,389,675
-
Share change
-
-193,182,224
-
Total reported value
-
$1,580,580
-
Price per share
-
$0.36
-
Number of holders
-
31
-
Value change
-
-$173,161,604
-
Number of buys
-
8
-
Number of sells
-
181
Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q1 2023
As of 31 Mar 2023,
SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,389,675 shares.
The largest 10 holders included
Paloma Partners Management Co, OAKTREE CAPITAL MANAGEMENT LP, Oaktree Fund Advisors, LLC, Crescent Grove Advisors, LLC, Lattice Capital Management, LLC, S&T Bank/PA, GoalVest Advisory LLC, Houlihan Financial Resource Group, Ltd., Valeo Financial Advisors, LLC, and Granite Bay Wealth Management, LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.